Health · 1 sources covering this

STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit

Kyverna Therapeutics is one step closer to launching the first cell therapy for an autoimmune disease, with new data in hand showing many patients remained off of other therapies a…

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit
Kyverna Therapeutics is one step closer to launching the first cell therapy for an autoimmune disease, with new data in hand showing many patients remained off of other therapies a…
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/698727234fc8387f001e77b7d193eada7b5806cd"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Kyverna&#8217;s cell therapy shows lasting autoimmune benefit"></iframe>

STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit

How 1 sources are covering this

STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit

More from Health

STAT+: Indonesian ruling against ‘patent evergreening’ by pharma industry sends critical message, patient advocates say

STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and more

STAT+: The rise of the AI-native radiology practice

One of the most contagious diseases on the planet is having its worst U.S. outbreak since 1991

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Kyverna&#8217;s cell therapy shows lasting autoimmune benefit

More from Health

STAT+: Indonesian ruling against &#8216;patent evergreening&#8217; by pharma industry sends critical message, patient advocates say

STAT+: Pharmalittle: We&#8217;re reading about the FDA commissioner nominee, a Lilly partnership in China, and more

STAT+: The rise of the AI-native radiology practice

One of the most contagious diseases on the planet is having its worst U.S. outbreak since 1991

Reader

Trust & legal

Across the network

STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit

STAT+: Indonesian ruling against ‘patent evergreening’ by pharma industry sends critical message, patient advocates say

STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and more